| Richard Hranac, MD | |
|
3219 Central Ave, Kearney, NE 68847-2949 | |
| (308) 865-2808 | |
| Not Available |
| Full Name | Richard Hranac |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Location | 3219 Central Ave, Kearney, Nebraska |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1720061930 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RN0300X | Internal Medicine - Nephrology | 12678 (Nebraska) | Secondary |
| 207R00000X | Internal Medicine | 12678 (Nebraska) | Primary |
| Entity Name | The Physician Network |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1437184652 PECOS PAC ID: 3476453267 Enrollment ID: O20040128001100 |
News Archive
Two grants from the National Institutes of Health will allow Saint Louis University researchers to build on breakthroughs in understanding the hepatitis B virus and begin the search for a drug to cure - not just halt - the illness.
A new study, published on the medRxiv* preprint server, has focused on the use of anti-nucleocapsid (N) antibody positivity as a marker of SARS-CoV-2 infection. In the present study, these antibody markers were evaluated using serological surveillance studies post-vaccination amidst circulation of variants of concern.
Pfizer Inc. announced today the discontinuation of A4021018 (also known as ADVIGO 1018), a Phase 3 trial examining the effects of investigational compound figitumumab (CP-751,871) in combination with erlotinib as a second/third-line treatment in patients with previously treated advanced non-adenocarcinoma non-small cell lung cancer (NSCLC).
A Loyola University Chicago study has found that abnormal proteins found in Alzheimer's disease, Parkinson's disease, and Huntington's disease all share a similar ability to cause damage when they invade brain cells.
Australian researchers have found a novel and easy way to detect a common and debilitating anxiety disorder called the Obsessive Compulsive Disorder or OCD. Scientists at the Centenary Institute in Sydney discovered a gene responsible for a rare kidney disorder is also behind OCD. This may make detecting OCD easier through a simple urine test. This test could also identify babies with risk of early-onset OCD. OCD affects up to 3 per cent of all Australians and in its worst cases can be completely debilitating, causing people to have to stay at home. OCD sufferers feel intense anxiety and are compelled to practice rituals - such as hand washing or arranging objects.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Richard Hranac, MD 3219 Central Ave, Kearney, NE 68847-2949 Ph: (308) 865-2808 | Richard Hranac, MD 3219 Central Ave, Kearney, NE 68847-2949 Ph: (308) 865-2808 |
News Archive
Two grants from the National Institutes of Health will allow Saint Louis University researchers to build on breakthroughs in understanding the hepatitis B virus and begin the search for a drug to cure - not just halt - the illness.
A new study, published on the medRxiv* preprint server, has focused on the use of anti-nucleocapsid (N) antibody positivity as a marker of SARS-CoV-2 infection. In the present study, these antibody markers were evaluated using serological surveillance studies post-vaccination amidst circulation of variants of concern.
Pfizer Inc. announced today the discontinuation of A4021018 (also known as ADVIGO 1018), a Phase 3 trial examining the effects of investigational compound figitumumab (CP-751,871) in combination with erlotinib as a second/third-line treatment in patients with previously treated advanced non-adenocarcinoma non-small cell lung cancer (NSCLC).
A Loyola University Chicago study has found that abnormal proteins found in Alzheimer's disease, Parkinson's disease, and Huntington's disease all share a similar ability to cause damage when they invade brain cells.
Australian researchers have found a novel and easy way to detect a common and debilitating anxiety disorder called the Obsessive Compulsive Disorder or OCD. Scientists at the Centenary Institute in Sydney discovered a gene responsible for a rare kidney disorder is also behind OCD. This may make detecting OCD easier through a simple urine test. This test could also identify babies with risk of early-onset OCD. OCD affects up to 3 per cent of all Australians and in its worst cases can be completely debilitating, causing people to have to stay at home. OCD sufferers feel intense anxiety and are compelled to practice rituals - such as hand washing or arranging objects.
› Verified 1 days ago
Ronald Dobesh, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 3219 Central Ave, Kearney, NE 68847 Phone: 308-865-2808 | |
Dr. John S Waters, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 10 E 31st St, Kearney, NE 68847 Phone: 308-865-7100 | |
Dr. Panayotis-alain Efstratiou, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 3219 Central Ave Ste 201, Kearney, NE 68847 Phone: 308-865-7271 | |
Dr. Meenakshi Ghosh, Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 3219 Central Ave Ste 200, Kearney, NE 68847 Phone: 308-865-2370 | |
Lissa Woodruff, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 3219 Central Ave, Kearney, NE 68847 Phone: 308-865-2808 | |
Dr. Anub George John, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 3219 Central Ave, Kearney, NE 68847 Phone: 308-865-7271 Fax: 308-865-2045 | |
Scott Smith, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 816 22nd Ave, Suite 100, Kearney, NE 68845 Phone: 308-865-2263 Fax: 308-865-2541 |